Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Apr 23;12(9):3069.
doi: 10.3390/jcm12093069.

Radiofrequency Ablation for Adenomyosis

Ioannis Dedes  1 , Georgios Kolovos  1 , Arrigo Fruscalzo  2 , David Toub  3 , Cloé Vaineau  1 , Susanne Lanz  1 , Sara Imboden  1 , Anis Feki  2 , Michael D Mueller  1
Affiliations
Review

Radiofrequency Ablation for Adenomyosis

Ioannis Dedes et al. J Clin Med. .

Abstract

Adenomyosis is a common benign gynecologic condition characterized by ectopic endometrial glands and stroma in the myometrium causing pain (dysmenorrhea) and abnormal uterine bleeding. New interventional techniques have been introduced over recent years. This study evaluates the treatment success and side effects of radiofrequency ablation. An electronic literature search in the PubMed, Scopus, and ScienceDirect databases was carried out on the outcomes of pain reduction and, secondarily, on abnormal uterine bleeding, reintervention, reproductive outcome, imaging outcome, and complications. There was a mean decrease in dysmenorrhea pain scores by -63.4 ± 9.0% at 12 months. Data on other outcome parameters were sparse. No major complications were reported. Radiofrequency ablation represents a promising minimally invasive and organ-preserving treatment in patients with symptomatic adenomyosis. It is associated with clinically meaningful improvement of adenomyosis-related pain in the short term.

Keywords: adenomyosis; hyperthermia; radiofrequency ablation.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Flowchart for study selection according to the PRISMA guidelines.
See this image and copyright information in PMC

References

    1. Nirgianakis K., Kalaitzopoulos D.R., Schwartz A.S.K., Spaanderman M., Kramer B.W., Mueller M.D., Mueller M. Fertility, pregnancy and neonatal outcomes of patients with adenomyosis: A systematic review and meta-analysis. Reprod. Biomed. Online. 2021;42:185–206. doi: 10.1016/j.rbmo.2020.09.023. - DOI - PubMed
    1. Horton J., Sterrenburg M., Lane S., Maheshwari A., Li T.C., Cheong Y. Reproductive, obstetric, and perinatal outcomes of women with adenomyosis and endometriosis: A systematic review and meta-analysis. Hum. Reprod. Update. 2019;25:592–632. doi: 10.1093/humupd/dmz012. - DOI - PubMed
    1. Upson K., Missmer S.A. Epidemiology of Adenomyosis. Semin. Reprod. Med. 2020;38:89–107. doi: 10.1055/s-0040-1718920. - DOI - PMC - PubMed
    1. Lazzeri L., Di Giovanni A., Exacoustos C., Tosti C., Pinzauti S., Malzoni M., Petraglia F., Zupi E. Preoperative and Postoperative Clinical and Transvaginal Ultrasound Findings of Adenomyosis in Patients with Deep Infiltrating Endometriosis. Reprod. Sci. 2014;21:1027–1033. doi: 10.1177/1933719114522520. - DOI - PubMed
    1. Pinzauti S., Lazzeri L., Tosti C., Centini G., Orlandini C., Luisi S., Zupi E., Exacoustos C., Petraglia F. Transvaginal sonographic features of diffuse adenomyosis in 18-30-year-old nulligravid women without endometriosis: Association with symptoms. Ultrasound Obstet. Gynecol. 2015;46:730–736. doi: 10.1002/uog.14834. - DOI - PubMed